These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34925006)

  • 21. Alterations in the relative abundance of
    Björkqvist O; Repsilber D; Seifert M; Brislawn C; Jansson J; Engstrand L; Rangel I; Halfvarson J
    Scand J Gastroenterol; 2019 May; 54(5):577-585. PubMed ID: 31104514
    [No Abstract]   [Full Text] [Related]  

  • 22. Genome-scale metabolic reconstructions of Bifidobacterium adolescentis L2-32 and Faecalibacterium prausnitzii A2-165 and their interaction.
    El-Semman IE; Karlsson FH; Shoaie S; Nookaew I; Soliman TH; Nielsen J
    BMC Syst Biol; 2014 Apr; 8():41. PubMed ID: 24708835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.
    Sokol H; Pigneur B; Watterlot L; Lakhdari O; Bermúdez-Humarán LG; Gratadoux JJ; Blugeon S; Bridonneau C; Furet JP; Corthier G; Grangette C; Vasquez N; Pochart P; Trugnan G; Thomas G; Blottière HM; Doré J; Marteau P; Seksik P; Langella P
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16731-6. PubMed ID: 18936492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis.
    Song H; Yoo Y; Hwang J; Na YC; Kim HS
    J Allergy Clin Immunol; 2016 Mar; 137(3):852-60. PubMed ID: 26431583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial Effects of Non-Encapsulated or Encapsulated Probiotic Supplementation on Microbiota Composition, Intestinal Barrier Functions, Inflammatory Profiles, and Glucose Tolerance in High Fat Fed Rats.
    Lee S; Kirkland R; Grunewald ZI; Sun Q; Wicker L; de La Serre CB
    Nutrients; 2019 Aug; 11(9):. PubMed ID: 31443365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probiotics as Complementary Treatment for Metabolic Disorders.
    Le Barz M; Anhê FF; Varin TV; Desjardins Y; Levy E; Roy D; Urdaci MC; Marette A
    Diabetes Metab J; 2015 Aug; 39(4):291-303. PubMed ID: 26301190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene co-expression network analysis of the human gut commensal bacterium Faecalibacterium prausnitzii in R-Shiny.
    Auger S; Mournetas V; Chiapello H; Loux V; Langella P; Chatel JM
    PLoS One; 2022; 17(11):e0271847. PubMed ID: 36399439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting: a pilot study.
    Remely M; Hippe B; Geretschlaeger I; Stegmayer S; Hoefinger I; Haslberger A
    Wien Klin Wochenschr; 2015 May; 127(9-10):394-8. PubMed ID: 25763563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faecalibacterium diversity in dairy cow milk.
    Savin KW; Zawadzki J; Auldist MJ; Wang J; Ram D; Rochfort S; Cocks BG
    PLoS One; 2019; 14(8):e0221055. PubMed ID: 31419254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probiotics: a proactive approach to health. A symposium report.
    Thomas LV; Suzuki K; Zhao J
    Br J Nutr; 2015 Dec; 114 Suppl 1():S1-15. PubMed ID: 26548336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma.
    Demirci M; Tokman HB; Uysal HK; Demiryas S; Karakullukcu A; Saribas S; Cokugras H; Kocazeybek BS
    Allergol Immunopathol (Madr); 2019; 47(4):365-371. PubMed ID: 30765132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin Biosynthesis by Human Gut Butyrate-Producing Bacteria and Cross-Feeding in Synthetic Microbial Communities.
    Soto-Martin EC; Warnke I; Farquharson FM; Christodoulou M; Horgan G; Derrien M; Faurie JM; Flint HJ; Duncan SH; Louis P
    mBio; 2020 Jul; 11(4):. PubMed ID: 32665271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Faecalibacterium prausnitzii (ATCC 27766) has preventive and therapeutic effects on chronic unpredictable mild stress-induced depression-like and anxiety-like behavior in rats.
    Hao Z; Wang W; Guo R; Liu H
    Psychoneuroendocrinology; 2019 Jun; 104():132-142. PubMed ID: 30844607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prebiotic Effect of an Organic Acid Mixture on
    Butucel E; Balta I; McCleery D; Marcu A; Stef D; Pet I; Callaway T; Stef L; Corcionivoschi N
    Biology (Basel); 2022 Dec; 12(1):. PubMed ID: 36671749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
    Fukui H
    Diseases; 2019 Nov; 7(4):. PubMed ID: 31726747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth-promoting effect of alginate on Faecalibacterium prausnitzii through cross-feeding with Bacteroides.
    Murakami R; Hashikura N; Yoshida K; Xiao JZ; Odamaki T
    Food Res Int; 2021 Jun; 144():110326. PubMed ID: 34053530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression.
    Jiang S; Xie S; Lv D; Zhang Y; Deng J; Zeng L; Chen Y
    Antonie Van Leeuwenhoek; 2016 Oct; 109(10):1389-96. PubMed ID: 27431681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Characterization of Novel
    Martín R; Miquel S; Benevides L; Bridonneau C; Robert V; Hudault S; Chain F; Berteau O; Azevedo V; Chatel JM; Sokol H; Bermúdez-Humarán LG; Thomas M; Langella P
    Front Microbiol; 2017; 8():1226. PubMed ID: 28713353
    [No Abstract]   [Full Text] [Related]  

  • 39. Butyrate mediates anti-inflammatory effects of
    Lenoir M; Martín R; Torres-Maravilla E; Chadi S; González-Dávila P; Sokol H; Langella P; Chain F; Bermúdez-Humarán LG
    Gut Microbes; 2020 Nov; 12(1):1-16. PubMed ID: 33054518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity.
    Remely M; Aumueller E; Jahn D; Hippe B; Brath H; Haslberger AG
    Benef Microbes; 2014 Mar; 5(1):33-43. PubMed ID: 24533976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.